All News about Acelyrin Inc
What 5 Analyst Ratings Have To Say About Acelyrin
November 28, 2023
Via Benzinga
Acelyrin, Inc. (NASDAQ:SLRN) Investor Alert: Lawsuit Alleges False and Misleading Statements
December 08, 2023
Via SBWire
Topics
Lawsuit
ACELYRIN, INC. Provides Update on Izokibep Clinical Development Program
November 27, 2023
From ACELYRIN, INC.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|